| CTRI Number |
CTRI/2024/07/071580 [Registered on: 30/07/2024] Trial Registered Prospectively |
| Last Modified On: |
10/06/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Vicharchikari Taila in treatment of Vicharchika |
|
Scientific Title of Study
|
Pharmaceutical Standardization And clinical Evaluation On Vicharchikari Taila In The Management Of Vicharchika. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Palak Sharma |
| Designation |
MD Scholar |
| Affiliation |
Dept Of Rasa Shastra Postgraduate Institute Of Ayurveda Dr S R Rajasthan Ayurved University Jodhpur |
| Address |
Dept Of Rasa shastra Postgraduate Institute Of Ayurveda Dr S R Rajasthan Ayurved University jodhpur
Jodhpur RAJASTHAN 342037 India |
| Phone |
9354130346 |
| Fax |
|
| Email |
sharmapalak0211@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
prof govind sahay shukla |
| Designation |
professor |
| Affiliation |
Postgraduate Institute Of Ayurveda |
| Address |
Dept Of Rasa shastra Postgraduate Institute Of Ayurveda Dr S R Rajasthan Ayurved University jodhpur Dept Of Rasa shastra Postgraduate Institute Of Ayurveda Dr S R Rajasthan Ayurved University jodhpur Jodhpur RAJASTHAN 342037 India |
| Phone |
08769058254 |
| Fax |
|
| Email |
dr.govindshukla@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Palak Sharma |
| Designation |
MD Scholar |
| Affiliation |
Dept Of Rasa Shastra Postgraduate Institute Of Ayurveda Dr S R Rajasthan Ayurved University Jodhpur |
| Address |
Dept Of Rasa shastra Postgraduate Institute Of Ayurveda Dr S R Rajasthan Ayurved University jodhpur
Jodhpur RAJASTHAN 342037 India |
| Phone |
9354130346 |
| Fax |
|
| Email |
sharmapalak0211@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dr S R Rajasthan Ayurved University, Karwar, Nagaur Road, Jodhpur |
|
|
Primary Sponsor
|
| Name |
Post Graduate Institue Of Ayurved, Jodhpur, Rajasthan |
| Address |
PGIA, Dr. S. R. Rajasthan Ayurved University, Jodhpur, Rajasthan , 342037 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Dr Palak Sharma |
Aman Medical Store, Chuli Gate, Near No.2 School, Gangapur City, Sawai Madhopur, Rajasthan , 322201 |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Palak Sharma |
Sanjeevani Hospital |
Room No 11 PGIA Dr S R Rajasthan Ayurved University Jodhpur Jodhpur RAJASTHAN |
9354130346
sharmapalak0211@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:L089||Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: VICARCIKA, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Vicharchikari Taila, Reference: Bhaishajya Ratnavali, Route: Topical, Dosage Form: Taila, Dose: 50(ml), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information: (2) Medicine Name: 30 Days, Reference: No, Route: -, Dosage Form: Taila, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information: |
|
|
|
Inclusion Criteria
|
| Age From |
14.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1. Patients 14-70 years of both sexes will be selected
2. Patients fulfilling the criteria of classical symptoms of Vicharchika like Kandu (Itching), Pidika (Papillae), Shyavavarna (Discoloration), Daha (Burning sensation), Rukshta (Dryness) and Ruja (Pain) will be selected for assessment.
3.Patients having complaints for less than 5 years.
|
|
| ExclusionCriteria |
| Details |
1.Patients below 14 and above 70 years.
2.Patients having complaints for more than 5 year.
3.Patients having pregnancy
4.Patient having any allergic history or sensitivity will be excluded from study
5.Patient having diabetes, will be excluded from present study.
|
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Other |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Relive in classical symptoms of Vicharchika. |
60 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Repigmentation and decrease in relapsing lesion of atopic dermatitis. |
60 days |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
03/02/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="1" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
As the skin is the largest Protective organ of human body, which is related to visual clinical speciality. The color of skin is important biologically, cosmetically and socially. It acts as an effective barrier against the entry of microbes. All the skin diseases in Ayurveda have been described under heading of ’kushtha’ which further divided into Mahakushtha and Kshudrakushtha. Vicharchika1 is one of kshudrakushtha runs a chronic course generally considered difficult to cure and even it is cured relapse is common, it is characterized with symptoms namely Kandu (Itching), Srava (Discharge), Pidika (Vesicles), and Shyava varna (Discoloration). The clinical representation of Vicharchika in modern dermatology is Eczema. Eczema or dermatitis is pattern of inflammatory response of skin which leads to delayed type hypersensitivity mediated by Memory T lymphocyte in skin. It is characterized by redness, skin oedema, itching and dryness with possible crusting, flaking, blistering, cracking & oozing or Bleeding. According to WHO almost 900 million people in the world are affected from skin diseases. Globally, skin and subcutaneous diseases was responsible for 42·9 million (95% UI 28·6–63·4) DALYs and 4·86 billion (4·68–5·06) incident cases in 2019. Globally, atopic dermatitis2 was responsible for 7·48 million (95% UI 3·99–12·6) DALYs and 24·4 million (23·3–25·6) incident cases in 2019. Vicharchikari taila3 is a poly-herbo mineral oil described in Kushtharogadhikara of bhaishajaya ratnavali . This formulation contains 17 drugs (Kutaj and shunti ) are used two times. 14 are Herbal drugs and 3 are Minerals. This formulation will help in breaking the pathology of Vicharchika as most of the drugs are having Kaphaghna4, Kandughna, Kushthaghna, Raktaprasadak & Vranashodhak properties. According to modern pharmacology these drugs possess Antiinflammatory, Antioxidant, Anti allergic, Anti histaminic, Antibacterial, Anti fungal, Blood purifier properties that are helpful in breaking pathogenesis of Vicharchika. In present world, modern medicines available for skin diseases are mostly steroids that are harmful for patient’s health. Overuse of steroids cause side effects and can also worsen the condition of patient. So, There is a need to standardize & study clinical trial of a herbal formulation(vicharchikari taila) that can reduce symptoms as well as has no side effects. |